Ocumension Therapeutics - ESG Rating & Company Profile powered by AI
Alternative companies in the rating peer group for Ocumension Therapeutics are shownin the table. Full Sustainability assessment of Ocumension Therapeutics can be reached by signing up for free. The ESG rating for Ocumension Therapeutics indicates its transparency towards the UN SDGs.
Ocumension Therapeutics in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Ocumension Therapeutics | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ocumension Therapeutics have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ocumension Therapeutics disclose current and historical energy intensity?
Sign up for free to unlockDoes Ocumension Therapeutics report the average age of the workforce?
Sign up for free to unlockDoes Ocumension Therapeutics reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ocumension Therapeutics disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ocumension Therapeutics disclose cybersecurity risks?
Sign up for free to unlockDoes Ocumension Therapeutics offer flexible work?
Sign up for free to unlockDoes Ocumension Therapeutics have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ocumension Therapeutics disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ocumension Therapeutics conduct supply chain audits?
Sign up for free to unlockDoes Ocumension Therapeutics disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ocumension Therapeutics conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ocumension Therapeutics disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ocumension Therapeutics disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ocumension Therapeutics disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ocumension Therapeutics disclose water use targets?
Sign up for free to unlockDoes Ocumension Therapeutics have careers partnerships with academic institutions?
Sign up for free to unlockDid Ocumension Therapeutics have a product recall in the last two years?
Sign up for free to unlockDoes Ocumension Therapeutics disclose incidents of discrimination?
Sign up for free to unlockDoes Ocumension Therapeutics allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ocumension Therapeutics issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ocumension Therapeutics disclose parental leave metrics?
Sign up for free to unlockDoes Ocumension Therapeutics disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ocumension Therapeutics disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ocumension Therapeutics disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ocumension Therapeutics support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ocumension Therapeutics disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ocumension Therapeutics reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ocumension Therapeutics involved in embryonic stem cell research?
Sign up for free to unlockDoes Ocumension Therapeutics disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ocumension Therapeutics disclose its waste policy?
Sign up for free to unlockDoes Ocumension Therapeutics report according to TCFD requirements?
Sign up for free to unlockDoes Ocumension Therapeutics disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ocumension Therapeutics disclose energy use targets?
Sign up for free to unlockDoes Ocumension Therapeutics disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ocumension Therapeutics have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ocumension Therapeutics
These potential risks are based on the size, segment and geographies of the company.
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.